Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.
2.

Seminal plasma and semen amyloids enhance cytomegalovirus infection in cell culture.

Tang Q, Roan NR, Yamamura Y.

J Virol. 2013 Dec;87(23):12583-91. doi: 10.1128/JVI.02083-13. Epub 2013 Sep 11.

3.

Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection.

Roan NR, Müller JA, Liu H, Chu S, Arnold F, Stürzel CM, Walther P, Dong M, Witkowska HE, Kirchhoff F, Münch J, Greene WC.

Cell Host Microbe. 2011 Dec 15;10(6):541-50. doi: 10.1016/j.chom.2011.10.010.

4.

Liquefaction of semen generates and later degrades a conserved semenogelin peptide that enhances HIV infection.

Roan NR, Liu H, Usmani SM, Neidleman J, Müller JA, Avila-Herrera A, Gawanbacht A, Zirafi O, Chu S, Dong M, Kumar ST, Smith JF, Pollard KS, Fändrich M, Kirchhoff F, Münch J, Witkowska HE, Greene WC.

J Virol. 2014 Jul;88(13):7221-34. doi: 10.1128/JVI.00269-14. Epub 2014 Apr 16.

5.

Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity.

Ren R, Yin S, Lai B, Ma L, Wen J, Zhang X, Lai F, Liu S, Li L.

Retrovirology. 2018 Jul 16;15(1):49. doi: 10.1186/s12977-018-0432-3.

6.

Effect of semen and seminal amyloid on vaginal transmission of simian immunodeficiency virus.

Münch J, Sauermann U, Yolamanova M, Raue K, Stahl-Hennig C, Kirchhoff F.

Retrovirology. 2013 Dec 5;10:148. doi: 10.1186/1742-4690-10-148.

7.

Enhancement of Ebola virus infection by seminal amyloid fibrils.

Bart SM, Cohen C, Dye JM, Shorter J, Bates P.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7410-7415. doi: 10.1073/pnas.1721646115. Epub 2018 Jun 25.

8.

Natural Seminal Amyloids as Targets for Development of Synthetic Inhibitors of HIV Transmission.

Sheik DA, Dewhurst S, Yang J.

Acc Chem Res. 2017 Sep 19;50(9):2159-2166. doi: 10.1021/acs.accounts.7b00154. Epub 2017 Aug 15. Review.

9.

Interaction of fibronectin with semen amyloids synergistically enhances HIV infection.

Roan NR, Chu S, Liu H, Neidleman J, Witkowska HE, Greene WC.

J Infect Dis. 2014 Oct 1;210(7):1062-6. doi: 10.1093/infdis/jiu220. Epub 2014 Apr 8.

10.

Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection.

Olsen JS, Brown C, Capule CC, Rubinshtein M, Doran TM, Srivastava RK, Feng C, Nilsson BL, Yang J, Dewhurst S.

J Biol Chem. 2010 Nov 12;285(46):35488-96. doi: 10.1074/jbc.M110.163659. Epub 2010 Sep 10.

11.

Gallic Acid Is an Antagonist of Semen Amyloid Fibrils That Enhance HIV-1 Infection.

LoRicco JG, Xu CS, Neidleman J, Bergkvist M, Greene WC, Roan NR, Makhatadze GI.

J Biol Chem. 2016 Jul 1;291(27):14045-55. doi: 10.1074/jbc.M116.718684. Epub 2016 May 11.

12.

Natural Inhibitor of Human Cytomegalovirus in Human Seminal Plasma.

Lippold S, Braun B, Krüger F, Harms M, Müller JA, Groß R, Münch J, von Einem J.

J Virol. 2019 Mar 5;93(6). pii: e01855-18. doi: 10.1128/JVI.01855-18. Print 2019 Mar 15.

13.

Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection).

Roan NR, Sowinski S, Münch J, Kirchhoff F, Greene WC.

J Biol Chem. 2010 Jan 15;285(3):1861-9. doi: 10.1074/jbc.M109.066167. Epub 2009 Nov 6.

14.

Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues.

Allen SA, Carias AM, Anderson MR, Okocha EA, Benning L, McRaven MD, Kelley ZL, Lurain J, Veazey RS, Hope TJ.

J Virol. 2015 May;89(10):5569-80. doi: 10.1128/JVI.00309-15. Epub 2015 Mar 4.

15.

Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide.

Olsen JS, DiMaio JT, Doran TM, Brown C, Nilsson BL, Dewhurst S.

J Biol Chem. 2012 Apr 6;287(15):11842-9. doi: 10.1074/jbc.M111.314336. Epub 2012 Feb 21.

16.

Inhibition of the enhancement of infection of human immunodeficiency virus by semen-derived enhancer of virus infection using amyloid-targeting polymeric nanoparticles.

Sheik DA, Brooks L, Frantzen K, Dewhurst S, Yang J.

ACS Nano. 2015 Feb 24;9(2):1829-1836. doi: 10.1021/nn5067254. Epub 2015 Feb 2.

17.

Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.

Sanchez MD, Ochoa AC, Foster TP.

Antiviral Res. 2016 Aug;132:13-25. doi: 10.1016/j.antiviral.2016.05.009. Epub 2016 May 15.

18.

Semen-derived amyloid fibrils drastically enhance HIV infection.

Münch J, Rücker E, Ständker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A, Giménez-Gallego G, Sánchez PC, Fowler DM, Koulov A, Kelly JW, Mothes W, Grivel JC, Margolis L, Keppler OT, Forssmann WG, Kirchhoff F.

Cell. 2007 Dec 14;131(6):1059-71.

19.

Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.

Kim KA, Yolamanova M, Zirafi O, Roan NR, Staendker L, Forssmann WG, Burgener A, Dejucq-Rainsford N, Hahn BH, Shaw GM, Greene WC, Kirchhoff F, Münch J.

Retrovirology. 2010 Jun 23;7:55. doi: 10.1186/1742-4690-7-55.

20.

Semen-derived enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen.

Easterhoff D, Ontiveros F, Brooks LR, Kim Y, Ross B, Silva JN, Olsen JS, Feng C, Hardy DJ, Dunman PM, Dewhurst S.

Antimicrob Agents Chemother. 2013 Jun;57(6):2443-50. doi: 10.1128/AAC.02464-12. Epub 2013 Mar 18.

Supplemental Content

Support Center